Taylor & Francis

Taylor & Francis began using Imagetwin within Dove Medical Press in 2022 as a standalone solution to strengthen image screening. Since then, the platform has been integrated via API into our submission system on selected journals, enabling scalable and automated screening across our workflow. Imagetwin’s duplication detection capabilities, supported by its extensive database, enhance our ability to conduct broader screening and ensure the authenticity of submitted figures. This integration supports efficiency, strengthens confidence in the editorial process, and reinforces our commitment to protecting the integrity and reputation of the research we publish.